Trade Summary

4 months ago, Sachs Bruce I, serving as Dir at Vertex Pharmaceuticals Inc / Ma (VRTX), purchased 5,000 shares at $389.68 per share, for a total transaction value of $1,948,416.00. Following this transaction, Sachs Bruce I now holds 45,000 shares of VRTX.

This purchase represents a 13.00% increase in Sachs Bruce I's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 6, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, August 7, 2025, 1 day after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.